Filing Details

Accession Number:
0001493152-21-023910
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-27 19:31:42
Reporting Period:
2021-09-24
Accepted Time:
2021-09-27 19:31:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1360214 Harrow Health Inc. HROW () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1242177 Md L Richard Lindstrom C/O Harrow Health, Inc.
102 Woodmont Blvd. Suite 610
Nashville TN 37205
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-09-24 3,900 $10.04 66,100 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 100,000 Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2021 and was terminated by the reporting person on September 24, 2021.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.01 to $10.08, inclusive. The reporting person undertakes to provide to Harrow Health, Inc. ("Harrow"), any security holder of Harrow, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. Represents shares held by the Lindstrom Family Limited Partnership No. 2, a limited partnership of which the reporting person is the general partner.